Legal Representation
Attorney
Pradeep Jayaraman
USPTO Deadlines
Next Deadline
1260 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-04-25)
Due Date
April 25, 2029
Grace Period Ends
October 25, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 20, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Aug 2, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Aug 2, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jul 25, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Apr 25, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 25, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 20, 2023 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Mar 1, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Mar 1, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Feb 7, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 7, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 7, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jan 18, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 18, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Jan 18, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Jan 4, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 1, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 30, 2022 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Nov 30, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 14, 2022 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 14, 2022 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 14, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Aug 25, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 22, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 22, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 22, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 11, 2022 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 21, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 21, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 18, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Feb 17, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 10, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 12, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 7, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 30, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical, surgical, and veterinary preparations for repairing nerves, for cardiovascular treatment; chemical preparations for medical, surgical, pharmaceutical or veterinary use for nerve repair, and cardiovascular treatment; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, and pharmaceutical preparations for nerve repair and cardiovascular treatment; capsules made of dendrimer-based polymers sold empty for pharmaceuticals, pharmaceutical preparations, namely, a drug delivery system comprising polymer based-oral tablets for the continuous release of a wide variety of therapeutic agents for medical, surgical, pharmaceutical, or veterinary use for nerve repair and cardiovascular treatment; adhesive, namely, glues and sealants for medical, surgical, pharmaceutical, or veterinary use for nerve repair and cardiovascular treatment; biological or chemical preparations for medical, surgical, pharmaceutical or veterinary use for nerve repair and cardiovascular treatment; diagnostic products, namely, medical diagnostic test media in the form of strips and medical preparations for medical use for nerve repair and cardiovascular treatment
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical, surgical and veterinary apparatus and instruments for nerve repair and cardiovascular treatment; medical devices for nerve repair and cardiovascular treatment, namely, device for improving nerve regeneration and repair, for reconnecting and protecting nerves; artificial hip, breast, larynx, and hand implants, joint, hip, breath, dental, bone prostheses, and artificial vascular grafts, connectors, joints, and substitutes for tendons; suture, fastening, artificial repair, and protection material for implants, prostheses, grafts, and tendons; syringes for medical or surgical use and applicators in the nature of syringe barrels for syringes for medical or surgical applications; surgical lamps; medical examination lamps; heating lamps for medical applications
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Biological and biochemical research services in the field of nerve repair and cardiovascular applications; scientific and technological research and development services, namely, chemical and medical chemistry research in the field of nerve repair and cardiovascular applications; research and development services for pharmaceutical products in the field of nerve repair and cardiovascular applications; medical research and clinical studies in the field of nerve repair and cardiovascular applications; quality control services for preparations and products for medical use for nerve repair and cardiovascular applications
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services in the field of nerve repair and cardiovascular applications; providing medical information in the field of nerve repair and cardiovascular applications treatment
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010
042
044